SYLVANT — RECORDATI RARE DISEASES, INC., approved 2019-12-05 (BLA125496).
663 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.